Lupin Pharmaceuticals Inc. recalls Cefdinir for Oral Suspension USP 125 mg/5 mL (60 mL when reconstituted)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Presence of foreign substance: Product complaint of foreign material in reconstituted bottle.
- Products
-
- Cefdinir for Oral Suspension USP 125 mg/5 mL (60 mL when reconstituted)
- Company
- Lupin Pharmaceuticals Inc.
- Where it was sold
-
USA nationwide
Nationwide
- Units affected
- 17,040 bottles
- About this recall
- Cefdinir for Oral Suspension USP 125 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046, India, NDC 68180-722-04